Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Titel:
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study
Auteur:
Ghofrani, Hossein-Ardeschir Simonneau, Gérald D'Armini, Andrea M Fedullo, Peter Howard, Luke S Jaïs, Xavier Jenkins, David P Jing, Zhi-Cheng Madani, Michael M Martin, Nicolas Mayer, Eckhard Papadakis, Kelly Richard, Dominik Kim, Nick H